commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any ...
SEOUL, Sept. 25 (Yonhap) -- CellBion Inc., a South Korean radiopharmaceuticals firm, plans to sell some 1.91 million new shares through an initial public offering on the secondary KOSDAQ market next ...